188 related articles for article (PubMed ID: 37191519)
1. Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae.
Domon H; Hirayama S; Isono T; Sasagawa K; Takizawa F; Maekawa T; Yanagihara K; Terao Y
Microbiol Spectr; 2023 Jun; 11(3):e0014823. PubMed ID: 37191519
[TBL] [Abstract][Full Text] [Related]
2. Clarithromycin Inhibits Pneumolysin Production via Downregulation of
Domon H; Isono T; Hiyoshi T; Tamura H; Sasagawa K; Maekawa T; Hirayama S; Yanagihara K; Terao Y
Microbiol Spectr; 2021 Oct; 9(2):e0031821. PubMed ID: 34468195
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Macrolide-Induced Inhibition of Pneumolysin Release Involves Impairment of Autolysin Release in Macrolide-Resistant Streptococcus pneumoniae.
Domon H; Maekawa T; Yonezawa D; Nagai K; Oda M; Yanagihara K; Terao Y
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181369
[No Abstract] [Full Text] [Related]
4. Macrolide Resistance in
Schroeder MR; Stephens DS
Front Cell Infect Microbiol; 2016; 6():98. PubMed ID: 27709102
[No Abstract] [Full Text] [Related]
5. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.
Wierzbowski AK; Karlowsky JA; Adam HJ; Nichol KA; Hoban DJ; Zhanel GG;
J Antimicrob Chemother; 2014 Jan; 69(1):59-66. PubMed ID: 23970485
[TBL] [Abstract][Full Text] [Related]
6. Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model.
Yasuda Y; Kasahara K; Mizuno F; Nishi K; Mikasa K; Kita E
Antimicrob Agents Chemother; 2007 May; 51(5):1741-52. PubMed ID: 17353244
[TBL] [Abstract][Full Text] [Related]
7. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
8. Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae.
Fukuda Y; Yanagihara K; Higashiyama Y; Miyazaki Y; Hirakata Y; Mukae H; Tomono K; Mizuta Y; Tsukamoto K; Kohno S
Eur Respir J; 2006 May; 27(5):1020-5. PubMed ID: 16455827
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and molecular characterization of macrolide resistance mechanisms among
Midouni Ayadi B; Mehiri E; Draoui H; Ghariani A; Essalah L; Raoult D; Fournier PE; Slim-Saidi LN
J Med Microbiol; 2020 Apr; 69(4):505-520. PubMed ID: 32159507
[No Abstract] [Full Text] [Related]
10. Molecular detection of genes responsible for macrolide resistance among Streptococcus pneumoniae isolated in North Lebanon.
El Ashkar S; Osman M; Rafei R; Mallat H; Achkar M; Dabboussi F; Hamze M
J Infect Public Health; 2017; 10(6):745-748. PubMed ID: 28215918
[TBL] [Abstract][Full Text] [Related]
11. Detection of pbp2b and ermB genes in clinical isolates of Streptococcus pneumoniae.
Kumari N; Navaratnam P; Sekaran SD
J Infect Dev Ctries; 2008 Jun; 2(3):193-9. PubMed ID: 19738350
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of azithromycin as the empiric therapy in children with community-acquired pneumonia who were isolated macrolide resistant Streptococcus pneumoniae from nasopharynx].
Nariai A; Okitsu N; Inoue M
Kansenshogaku Zasshi; 2004 Jun; 78(6):490-5. PubMed ID: 15287476
[TBL] [Abstract][Full Text] [Related]
13. Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece.
Grivea IN; Sourla A; Ntokou E; Chryssanthopoulou DC; Tsantouli AG; Syrogiannopoulos GA
BMC Infect Dis; 2012 Oct; 12():255. PubMed ID: 23057516
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway.
Littauer P; Sangvik M; Caugant DA; Høiby EA; Simonsen GS; Sundsfjord A;
J Clin Microbiol; 2005 May; 43(5):2125-32. PubMed ID: 15872231
[TBL] [Abstract][Full Text] [Related]
15. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae.
Rzeszutek M; Wierzbowski A; Hoban DJ; Conly J; Bishai W; Zhanel GG
Int J Antimicrob Agents; 2004 Aug; 24(2):95-104. PubMed ID: 15288306
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of multidrug-resistant international clones among macrolide-resistant Streptococcus pneumoniae isolates in immunocompromised patients in Tunisia.
Raddaoui A; Tanfous FB; Chebbi Y; Achour W; Baaboura R; Benhassen A
Int J Antimicrob Agents; 2018 Dec; 52(6):893-897. PubMed ID: 29698665
[TBL] [Abstract][Full Text] [Related]
17. Positive association between the use of macrolides in food-producing animals and pneumococcal macrolide resistance: a global ecological analysis.
Kenyon C
Int J Infect Dis; 2022 Mar; 116():344-347. PubMed ID: 35038599
[TBL] [Abstract][Full Text] [Related]
18. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.
Farrell DJ; Morrissey I; Bakker S; Felmingham D
J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():39-47. PubMed ID: 12239227
[TBL] [Abstract][Full Text] [Related]
20. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
Jenkins SG; Brown SD; Farrell DJ
Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
